Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.02101 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.96529 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.0365 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.12225 | 93 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.0363 | 93 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.42499 | 92 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.69054 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.66301 | 92 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.98597 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.30837 | 95 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.36477 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.30373 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.2376 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.15422 | 94 |